Novartis Q4 Earnings: Revenue And EPS Beat, CEO Dismisses Entresto Patent Expiration Worries

aol.com/novartis-q4-earnings-revenue-eps-132637315.html

Novartis AG (NYSE:NVS) shares are trading higher in the premarket session on Friday.
The Swiss pharma giant reported fourth-quarter adjusted earnings per share of $1.98, beating the street view of $1.81. Quarterly sales of $13.153 billion outpaced the analyst consensus estimate of $12.811…

This story appeared on aol.com, 2025-01-31 14:00:28.414000.
The Entire Business World on a Single Page. Free to Use →